$RKDA
Arcadia Biosciences, Inc.

2019 Q1 Form 10-Q Financial Statement

#000156459019017310 Filed on May 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $158.0K $214.0K
YoY Change -26.17% -78.98%
Cost Of Revenue $60.00K $36.00K
YoY Change 66.67% -66.04%
Gross Profit $100.0K $178.0K
YoY Change -43.82% -80.48%
Gross Profit Margin 63.29% 83.18%
Selling, General & Admin $2.812M $2.621M
YoY Change 7.29% -14.12%
% of Gross Profit 2812.0% 1472.47%
Research & Development $1.505M $1.396M
YoY Change 7.81% -23.42%
% of Gross Profit 1505.0% 784.27%
Depreciation & Amortization $34.00K $50.00K
YoY Change -32.0% -37.5%
% of Gross Profit 34.0% 28.09%
Operating Expenses $4.376M $4.053M
YoY Change 7.97% -18.63%
Operating Profit -$4.218M -$3.839M
YoY Change 9.87% -3.13%
Interest Expense -$8.500M -$1.900M
YoY Change 347.37% -660.47%
% of Operating Profit
Other Income/Expense, Net $120.0K $38.00K
YoY Change 215.79% -60.42%
Pretax Income -$12.59M -$10.61M
YoY Change 18.72% 152.14%
Income Tax $19.00K $10.00K
% Of Pretax Income
Net Earnings -$12.61M -$10.62M
YoY Change 18.81% 151.78%
Net Earnings / Revenue -7982.28% -4960.28%
Basic Earnings Per Share -$2.64
Diluted Earnings Per Share -$2.64 -$4.849M
COMMON SHARES
Basic Shares Outstanding 4.777M
Diluted Shares Outstanding 4.777M

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.79M $20.42M
YoY Change -12.88% -57.92%
Cash & Equivalents $10.44M $20.42M
Short-Term Investments $7.360M $0.00
Other Short-Term Assets $510.0K $420.0K
YoY Change 21.43% -67.19%
Inventory $187.0K $310.0K
Prepaid Expenses
Receivables $79.00K $100.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $18.57M $21.25M
YoY Change -12.64% -57.87%
LONG-TERM ASSETS
Property, Plant & Equipment $460.0K $280.0K
YoY Change 64.29% -42.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $730.0K $7.000K
YoY Change 10328.57% -99.59%
Total Long-Term Assets $3.385M $1.349M
YoY Change 150.93% -38.96%
TOTAL ASSETS
Total Short-Term Assets $18.57M $21.25M
Total Long-Term Assets $3.385M $1.349M
Total Assets $21.95M $22.60M
YoY Change -2.87% -57.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.00K $0.00
YoY Change -100.0%
Accrued Expenses $570.0K
YoY Change
Deferred Revenue $56.00K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $2.970M $3.032M
YoY Change -2.04% -41.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $3.000M $3.000M
YoY Change 0.0% -50.08%
Total Long-Term Liabilities $3.000M $3.000M
YoY Change 0.0% -87.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.970M $3.032M
Total Long-Term Liabilities $3.000M $3.000M
Total Liabilities $21.32M $21.93M
YoY Change -2.8% -36.02%
SHAREHOLDERS EQUITY
Retained Earnings -$191.0M -$175.5M
YoY Change 8.82%
Common Stock $191.6M $176.2M
YoY Change 8.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $630.0K $667.0K
YoY Change
Total Liabilities & Shareholders Equity $21.95M $22.60M
YoY Change -2.87% -57.08%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$12.61M -$10.62M
YoY Change 18.81% 151.78%
Depreciation, Depletion And Amortization $34.00K $50.00K
YoY Change -32.0% -37.5%
Cash From Operating Activities -$3.969M -$2.617M
YoY Change 51.66% -42.23%
INVESTING ACTIVITIES
Capital Expenditures $88.00K $33.00K
YoY Change 166.67% -42.11%
Acquisitions
YoY Change
Other Investing Activities $2.510M $3.910M
YoY Change -35.81% -61.36%
Cash From Investing Activities $2.422M $3.876M
YoY Change -37.51% -61.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.00K 10.03M
YoY Change -100.13% 50070.0%
NET CHANGE
Cash From Operating Activities -3.969M -2.617M
Cash From Investing Activities 2.422M 3.876M
Cash From Financing Activities -13.00K 10.03M
Net Change In Cash -1.560M 11.29M
YoY Change -113.81% 103.48%
FREE CASH FLOW
Cash From Operating Activities -$3.969M -$2.617M
Capital Expenditures $88.00K $33.00K
Free Cash Flow -$4.057M -$2.650M
YoY Change 53.09% -42.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2193000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2645000
CY2019Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
56000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
96000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
574000
CY2019Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
264000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
284000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1771000
CY2019Q1 rkda Common Stock Warrant Liabilities
CommonStockWarrantLiabilities
13578000
CY2018Q4 rkda Common Stock Warrant Liabilities
CommonStockWarrantLiabilities
5083000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3072000
CY2018Q4 us-gaap Liabilities
Liabilities
11209000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
45000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
191136000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178366000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
158000
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
214000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1505000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2812000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
4376000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4218000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
120000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
38000
CY2018Q1 rkda Initial Loss On Common Stock Warrant And Common Stock Adjustment Feature Liabilities
InitialLossOnCommonStockWarrantAndCommonStockAdjustmentFeatureLiabilities
4000000
CY2019Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
8495000
CY2018Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1900000
CY2018Q1 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
904000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10438000
CY2019Q1 us-gaap Short Term Investments
ShortTermInvestments
7355000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
79000
CY2018Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3000
CY2019Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Inventory Net
InventoryNet
181000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
704000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
22876000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
395000
CY2019Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
701000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000
CY2018Q4 us-gaap Assets
Assets
24024000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1396000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q1 us-gaap Inventory Net
InventoryNet
187000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4774919
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
506000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
18565000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
460000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
12815000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24024000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4774919
CY2018Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
29000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3000000
CY2019Q1 us-gaap Liabilities
Liabilities
21317000
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
45000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
191566000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-190978000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2621000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3839000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
4053000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-12593000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-10605000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-12612000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-10615000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.64
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.86
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4776540
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2186196
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12612000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10614000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
8007000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
963000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
526000
CY2018 rkda Adjustments To Additional Paid In Capital Reclassification Of Common Stock Adjustment Feature Liability To Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfCommonStockAdjustmentFeatureLiabilityToEquity
8378000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1550000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-13480000
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
422000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
34000
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
52000
CY2019Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
172000
CY2018Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3000
CY2019Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
39000
CY2018Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
422000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
298000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-86000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1179000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-3000
CY2018Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
45000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-39000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-21000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-197000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-137000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-322000
CY2018Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-25000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-40000
CY2018Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-96000
CY2019Q1 rkda Increase Decrease In Operating Lease Payments
IncreaseDecreaseInOperatingLeasePayments
-172000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3969000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2617000
CY2018Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
9000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33000
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6690000
CY2019Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
9200000
CY2018Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
3900000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2422000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3876000
CY2018Q1 rkda Proceeds From Issuance Of Common Stock And Warrants From Purchase Agreement
ProceedsFromIssuanceOfCommonStockAndWarrantsFromPurchaseAgreement
10000000
CY2018Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
932000
CY2019Q1 rkda Payments Of Offering Costs
PaymentsOfOfferingCosts
16000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1560000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9125000
CY2019Q1 rkda Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
5000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
966000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10034000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11293000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20418000
CY2019Q1 rkda Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses
OfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses
7000
CY2018Q1 rkda Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses
OfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses
334000
CY2019Q1 rkda Deferred Stock Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses
DeferredStockOfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses
18000
CY2018Q1 rkda Warrant Issued Included In Offering Costs
WarrantIssuedIncludedInOfferingCosts
526000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2328000
CY2018Q1 rkda Proceeds From Sale Of Fixed Assets Included In Prepaid Expenses And Other Current Assets
ProceedsFromSaleOfFixedAssetsIncludedInPrepaidExpensesAndOtherCurrentAssets
1000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13000
CY2019Q1 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Arizona
CY2019Q1 rkda Entity Incorporation Year Of Incorporation
EntityIncorporationYearOfIncorporation
2002
CY2019Q1 rkda Entity Reincorporation State Country Name
EntityReincorporationStateCountryName
Delaware
CY2019Q1 rkda Entity Reincorporation Date Of Reincorporation
EntityReincorporationDateOfReincorporation
2015-03
CY2019Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:20
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13600000
CY2019Q1 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
41000
CY2018Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
41000
CY2019Q1 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
847000
CY2018Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
886000
CY2019Q1 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
888000
CY2018Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
927000
CY2019Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
17281000
CY2019Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2019Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2019Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
17281000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
21072000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
21072000
CY2019Q1 rkda Available For Sale Securities Continuous Unrealized Loss Position For More Than Three Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionForMoreThanThreeMonthsAccumulatedLoss
0
CY2019Q1 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
0
CY2018Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
0
CY2019Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
0
CY2019Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
17281000
CY2018Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
21072000
CY2019Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
243000
CY2018Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
286000
CY2019Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
Some leases (the warehouse, greenhouse and the Phoenix copier) include one or more options to renew, with renewal terms that can extend the lease term from one to six years.
CY2019Q1 rkda Operating Lease Assets
OperatingLeaseAssets
2193000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2345000
CY2019Q1 us-gaap Lease Cost
LeaseCost
208000
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2019Q1 us-gaap Share Price
SharePrice
32.52
CY2019Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2019Q1 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
4000000
CY2018Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
15900000
CY2018Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-1900000
CY2019Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000
CY2019Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
50000000
CY2019Q1 rkda Fair Value Of Common Stock Warrants At Inception
FairValueOfCommonStockWarrantsAtInception
9000000
CY2019Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
226000
CY2019Q1 rkda Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
530044
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7500
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1287
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1014
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
535243
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
526131
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
231086
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.53
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.57
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.33
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
24.78
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.13
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
35.47
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
60.40
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
637000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
623000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
182000
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
900000
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000
CY2019Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2821144
CY2019Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
18.15
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2019Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3356387
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
635199

Files In Submission

Name View Source Status
0001564590-19-017310-index-headers.html Edgar Link pending
0001564590-19-017310-index.html Edgar Link pending
0001564590-19-017310.txt Edgar Link pending
0001564590-19-017310-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rkda-10q_20190331.htm Edgar Link pending
rkda-20190331.xml Edgar Link completed
rkda-20190331.xsd Edgar Link pending
rkda-20190331_cal.xml Edgar Link unprocessable
rkda-20190331_def.xml Edgar Link unprocessable
rkda-20190331_lab.xml Edgar Link unprocessable
rkda-20190331_pre.xml Edgar Link unprocessable
rkda-ex311_8.htm Edgar Link pending
rkda-ex312_9.htm Edgar Link pending
rkda-ex321_6.htm Edgar Link pending
rkda-ex322_7.htm Edgar Link pending
Show.js Edgar Link pending